Frailty in Hematologic Malignancy Thuy T. KollAshley E. Rosko Health Economics (N Khera, Section Editor) 05 May 2018 Pages: 143 - 154
The Effect of Psychosocial Interventions on Outcomes for Caregivers of Hematopoietic Cell Transplant Patients Lauren R. BangerterJoan M. GriffinNandita Khera Health Economics (N Khera, Section Editor) 28 April 2018 Pages: 155 - 163
Management of Myelofibrosis-Related Cytopenias Prithviraj BoseSrdan Verstovsek Myeloproliferative Neoplasms (B Stein, Section Editor) 23 May 2018 Pages: 164 - 172
Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis Francesco PassamontiBarbara MoraMargherita Maffioli Myeloproliferative Neoplasms (B Stein, Section Editor) 30 April 2018 Pages: 173 - 182
Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms Imo J. AkpanBrady Lee Stein Myeloproliferative Neoplasms (B Stein, Section Editor) 11 April 2018 Pages: 183 - 190
Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes Melanie C. DispenzaBruce S. Bochner Myeloproliferative Neoplasms (B Stein, Section Editor) 21 April 2018 Pages: 191 - 201
Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making James A. KennedyGabriela Hobbs Myeloproliferative Neoplasms (B Stein, Section Editor) 23 April 2018 Pages: 202 - 211
Novel Approaches for the Management of AL Amyloidosis Nisha S. JosephJonathan L. Kaufman Multiple Myeloma (P Kapoor, Section Editor) 14 June 2018 Pages: 212 - 219
Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney—What We Know and What the Future May Hold Sandhya ManoharSamih H. NasrNelson Leung Multiple Myeloma (P Kapoor, Section Editor) 03 May 2018 Pages: 220 - 226
How We Manage Patients with Plasmacytomas Despina FotiouMeletios A. DimopoulosEfstathios Kastritis Multiple Myeloma (P Kapoor, Section Editor) 17 April 2018 Pages: 227 - 235